D-0193-2025 Class III Ongoing
FDA drug recall D-0193-2025 was initiated by Akron Pharma, Inc. on December 12, 2024 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID. The recall status is ongoing. Affected quantity: 768 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- January 22, 2025
- Initiation Date
- December 12, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 768 bottles
Product Description
Acetaminophen Extra Strength 500 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8022-01.
Reason for Recall
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Distribution Pattern
Nationwide in the US
Code Information
Lot: KDT0224002A, Exp 09/30/2026